Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · IEX Real-Time Price · USD
1.76
0.00 (0.00%)
At close:
Mar 17, 2023, 12:00 AM
1.82
+0.06 (3.41%)
Pre-market:
Mar 20, 2023, 8:23 AM EDT
CRDF Market Cap
Cardiff Oncology has a market cap or net worth of $76.84 million as of March 20, 2023. Its market cap has decreased by -27.43% in one year.
Market Cap
76.84M
Enterprise Value
-23.92M
1-Year Change
-27.43%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since July 27, 2004, Cardiff Oncology, Inc.'s market cap has decreased from $72.38B to $76.84M, a decrease of -99.89%. That is a compound annual growth rate of -30.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 17, 2023 | 76.84M | -2.82% |
Mar 16, 2023 | 79.08M | 2.91% |
Mar 15, 2023 | 76.84M | -2.27% |
Mar 14, 2023 | 78.63M | 2.92% |
Mar 13, 2023 | 76.40M | -1.16% |
Mar 10, 2023 | 77.29M | -3.89% |
Mar 9, 2023 | 80.42M | -11.33% |
Mar 8, 2023 | 90.69M | 9.73% |
Mar 7, 2023 | 82.65M | 7.56% |
Mar 6, 2023 | 76.84M | -2.27% |
Mar 3, 2023 | 78.63M | 1.73% |
Mar 2, 2023 | 77.29M | 0.58% |
Mar 1, 2023 | 76.84M | -0.58% |
Feb 28, 2023 | 77.29M | 5.49% |
Feb 27, 2023 | 73.27M | - |
Feb 24, 2023 | 73.27M | -7.34% |
Feb 23, 2023 | 79.08M | 7.27% |
Feb 22, 2023 | 73.72M | -1.20% |
Feb 21, 2023 | 74.61M | -11.64% |
Feb 17, 2023 | 84.44M | -1.05% |
Feb 16, 2023 | 85.33M | 2.14% |
Feb 15, 2023 | 83.55M | - |
Feb 14, 2023 | 83.55M | 2.75% |
Feb 13, 2023 | 81.31M | -5.21% |
Feb 10, 2023 | 85.78M | 7.87% |
View and export this data all the way back to 2004.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reneo Pharmaceuticals, Inc. | 106.21M |
Aligos Therapeutics, Inc. | 55.82M |
Daxor Corporation | 41.41M |
Sensei Biotherapeutics, Inc. | 40.24M |
Cryo-Cell International, Inc. | 31.28M |
Novan, Inc. | 29.11M |
Vaccinex, Inc. | 21.28M |
RedHill Biopharma Ltd. | 16.43M |